0 Σχόλια
0 Μοιράστηκε
150 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
- Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
- Blood Cancer Drugs Market Analysis: R&D Trends, DROC Insights, and Key StakeholdersAccording to recent insights by DataM Intelligence, the blood cancer drugs market is projected to reach USD 75.4 billion by 2032, up from an estimated USD 38.9 billion in 2024. This surge is fueled by rising incidences of hematologic malignancies, greater accessibility to treatment in advanced economies, and consistent innovation by major pharmaceutical players. The projected compound annual...0 Σχόλια 0 Μοιράστηκε 299 Views 0 Προεπισκόπηση
- CAR-T Cell Therapy Market Set for Massive Growth, USD 67.62 Bn by 2032The Global CAR-T Cell Therapy Market was valued at US$ 2.15 billion in 2024 and is projected to reach US$ 15.8 billion by 2033, registering a CAGR of 23.1% during the forecast period 2025–2033. The market is expanding rapidly due to rising demand for personalized cancer treatments and innovations in immunotherapy. Advances in genetic engineering, cell modification technologies, and...0 Σχόλια 0 Μοιράστηκε 75 Views 0 Προεπισκόπηση
- Lentiviral Vector Market Overview, Growth Analysis, Trends and Forecast By 2032"Key Drivers Impacting Executive Summary Lentiviral Vector Market Size and Share During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.90%, primarily driven by the rising demand for gene and cell therapies, especially in the treatment of cancer and genetic disorders The credible Lentiviral Vector Marketreport comprises of various segments linked...0 Σχόλια 0 Μοιράστηκε 80 Views 0 Προεπισκόπηση
- Lentiviral Vector Market Overview, Growth Analysis, Trends and Forecast By 2032"Key Drivers Impacting Executive Summary Lentiviral Vector Market Size and Share During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.90%, primarily driven by the rising demand for gene and cell therapies, especially in the treatment of cancer and genetic disorders. The credible Lentiviral Vector Marketreport comprises of various segments linked to...0 Σχόλια 0 Μοιράστηκε 26 Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων